These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 5463286
21. Acute effect of large doses of calcitonin on calcium, magnesium and inorganic phosphate levels in rat serum in correlation to differences in thryroid function. Neradilová M, Blahosová A, Reisenauer R. Physiol Bohemoslov; 1977 Aug; 26(4):331-6. PubMed ID: 144283 [Abstract] [Full Text] [Related]
22. Serum citric acid in Paget's disease. KISSIN B, KREEGER N. Am J Med Sci; 1954 Sep; 228(3):301-5. PubMed ID: 13197381 [No Abstract] [Full Text] [Related]
23. Effect of calcitonin on blood magnesium, calcium, inorganic phosphates and urea in rats with acute experimental uremia. Madry K, Lutz W, Papiernik E. Mater Med Pol; 1977 Sep; 9(1):14-8. PubMed ID: 875447 [No Abstract] [Full Text] [Related]
24. [Analysis of disorders of the principal pathways of calcium metabolism in Paget's disease. Effects of calcitonin administration. 26 cases]. Coutris G, Cayla J, Rondier J, Talbot JN, Bonvarlet JP, Milhaud G. Rev Rhum Mal Osteoartic; 1975 Dec; 42(12):759-67. PubMed ID: 1224161 [Abstract] [Full Text] [Related]
25. Influence of pharmacological doses of calcitonin on serum osteocalcin concentration in patients with Paget's disease of the bone. Mulder H, Schop C, Koster JC. Acta Endocrinol (Copenh); 1989 Jun; 120(6):721-3. PubMed ID: 2786309 [Abstract] [Full Text] [Related]
26. [Clinical and metabolic studies of Paget's bone disease treated with thyrocalcitonin (author's transl)]. Kocián J. Cas Lek Cesk; 1981 May 14; 120(19):571-5. PubMed ID: 7237502 [No Abstract] [Full Text] [Related]
27. [Parathyroid function in Paget's disease of bone]. Chapuy MC, Zucchelli P, Meunier PJ. Rev Rhum Mal Osteoartic; 1982 Feb 14; 49(2):99-102. PubMed ID: 7063800 [Abstract] [Full Text] [Related]
28. [Test for hypocalcemia due to calcitonin in the normal subject and in patients with osteoporosis or Paget's disease. Preliminary results]. Renier JC, Bernat M, Brégeon C, Gallois Y, Rebel A, Basle M, Auvinet B, Pitois M. Rev Rhum Mal Osteoartic; 1975 Dec 14; 42(12):731-7. PubMed ID: 1224158 [Abstract] [Full Text] [Related]
36. [Development, chemistry, and clinical pharmacology of fully synthetic human calcitonin (author's transl)]. Hobitz H. Wien Klin Wochenschr; 1982 Feb 05; 94(3):67-75. PubMed ID: 7043901 [Abstract] [Full Text] [Related]
37. Tubular excretion of phosphate in Paget's disease of bone. Effect of pamidronate. Constantin A, Laroche M, Moulinier L, Bon E, Ramonjisoa M, Cantagrel A, Mazieres B. Rev Rhum Engl Ed; 1995 Feb 05; 62(7-8):493-500. PubMed ID: 8574612 [Abstract] [Full Text] [Related]
38. Some acute effects of administered porcine calcitonin in man. Singer FR, Woodhouse NJ, Parkinson DK, Joplin GF. Clin Sci; 1969 Aug 05; 37(1):181-90. PubMed ID: 5387728 [No Abstract] [Full Text] [Related]
39. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone]. Nuti R, Turchetti V, Righi G, Vattimo A. Minerva Med; 1982 Mar 03; 73(9):467-72. PubMed ID: 6801555 [Abstract] [Full Text] [Related]
40. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?]. Davoine GA, Jung A, Courvoisier B. Schweiz Med Wochenschr; 1981 Apr 11; 111(15):518-24. PubMed ID: 6785879 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]